{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:21:24Z","timestamp":1789755684497,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China Youth Science Foundation","award":["NO.82204562"],"award-info":[{"award-number":["NO.82204562"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03164-0","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:29:40Z","timestamp":1756279780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Folate-modified liposomes for co-delivery of schisandrin A and oxaliplatin to enhance colorectal cancer cell death"],"prefix":"10.1007","volume":"16","author":[{"given":"Bo","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WanRu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"issue":"3","key":"3164_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00262-024-03641-5","volume":"73","author":"M De Silva","year":"2024","unstructured":"De Silva M, Tse BCY, Diakos CI, Clarke S, Molloy MP. Immunogenic cell death in colorectal cancer: a review of mechanisms and clinical utility. Cancer Immunol Immunother. 2024;73(3):53.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"3164_CR2","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1038\/s41467-020-17670-y","volume":"11","author":"C Robert","year":"2020","unstructured":"Robert C. A decade of immune-checkpoint inhibitors in cancer therapy. Nat Commun. 2020;11(1):3801.","journal-title":"Nat Commun"},{"issue":"1","key":"3164_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41392-023-01545-x","volume":"8","author":"M Luo","year":"2023","unstructured":"Luo M, Wang X, Wu S, Yang C, Su Q, Huang L, Fu K, An S, Xie F, To KKW, Wang F, Fu L. A20 promotes colorectal cancer immune evasion by upregulating STC1 expression to block eat-me signal. Signal Transduct Target Ther. 2023;8(1):312.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"3164_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nri.2016.153","volume":"17","author":"S Nagata","year":"2017","unstructured":"Nagata S, Tanaka M. Programmed cell death and the immunesystem[J]. Nat Rev Immunol. 2017;17(5):333\u201340.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"3164_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nri2215","volume":"8","author":"H Kono","year":"2008","unstructured":"Kono H, Rock KL. How dying cells alert the immune system todanger[J]. Nat Rev Immunol. 2008;8(4):279\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"3164_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/path.2866","volume":"224","author":"S Ladoire","year":"2011","unstructured":"Ladoire S, Mignot G, Dabakuyo S, et al. In situ immune responseafter neoadjuvant chemotherapy for breast cancer predicts survival[J]. J Pathol. 2011;224(3):389\u2013400.","journal-title":"J Pathol"},{"issue":"4","key":"3164_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/CJI.0b013e3181d32f01","volume":"33","author":"P Correale","year":"2010","unstructured":"Correale P, Rotundo MS, Del Vecchio MT, et al. Regulatory (FoxP3+)T-cell tumor infiltration is a favorable prognostic factor in advancedcolon cancer patients undergoing chemo or chemoimmunotherapy[J]. J Immunother. 2010;33(4):435\u201341.","journal-title":"J Immunother"},{"issue":"9","key":"3164_CR8","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/nm1622","volume":"13","author":"L Apetoh","year":"2007","unstructured":"Apetoh L, Ghiringhelli F, Tesniere A, et al. Toll-like receptor4-dependent contribution of the immune system to anticancerchemotherapy and radiotherapy[J]. Nat Med. 2007;13(9):1050\u20139.","journal-title":"Nat Med"},{"key":"3164_CR9","doi-asserted-by":"crossref","unstructured":"Pol J, Vacchelli E, ArandA F et al. Trial watch: Immunogenic celldeath inducers for anticancer chemotherapy[J]. Oncoimmunology 2015, 4(4): e1008866.","DOI":"10.1080\/2162402X.2015.1008866"},{"issue":"9","key":"3164_CR10","first-page":"643","volume":"3","author":"N Rufo","year":"2017","unstructured":"Rufo N, Garg AD, Agostinis P. The unfolded protein response inimmunogenic cell death and cancer immunotherapy[J]. TrendsCancer. 2017;3(9):643\u201358.","journal-title":"TrendsCancer"},{"issue":"21","key":"3164_CR11","doi-asserted-by":"publisher","first-page":"e202300662","DOI":"10.1002\/anie.202300662","volume":"62","author":"L Zhang","year":"2023","unstructured":"Zhang L, Montesdeoca N, Karges J, Xiao H. Immunogenic cell death inducing metal complexes for Cancer therapy. Angew Chem Int Ed Engl. 2023;62(21):e202300662.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"12","key":"3164_CR12","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and damps in cancer therapy. Nat Rev Cancer. 2012;12(12):860\u201375.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"3164_CR13","first-page":"4850","volume":"129","author":"Z Wang","year":"2019","unstructured":"Wang Z, Chen J, Hu J, et al. cGAS\/STING axis mediates atopoisomerase II inhibitor-induced tumor immunogenicity[J]. J ClinInvest. 2019;129(11):4850\u201362.","journal-title":"J ClinInvest"},{"issue":"6","key":"3164_CR14","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s13402-020-00552-2","volume":"43","author":"H Zhu","year":"2020","unstructured":"Zhu H, Shan Y, Ge K, Lu J, Kong W, Jia C. Oxaliplatin induces Immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint Blockade therapy. Cell Oncol (Dordr). 2020;43(6):1203\u201314.","journal-title":"Cell Oncol (Dordr)"},{"issue":"4","key":"3164_CR15","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/onc.2009.356","volume":"29","author":"A Tesniere","year":"2010","unstructured":"Tesniere A, Schlemmer F, Boige V, Kepp O, Martins I, Ghiringhelli F, Aymeric L, Michaud M, Apetoh L, Barault L, Mendiboure J, Pignon JP, Jooste V, van Endert P, Ducreux M, Zitvogel L, Piard F, Kroemer G. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene. 2010;29(4):482\u201391.","journal-title":"Oncogene"},{"issue":"6","key":"3164_CR16","doi-asserted-by":"publisher","first-page":"1802134","DOI":"10.1002\/advs.201802134","volume":"6","author":"Q Chen","year":"2019","unstructured":"Chen Q, Liu L, Lu Y, Chen X, Zhang Y, Zhou W, Guo Q, Li C, Zhang Y, Zhang Y, Liang D, Sun T, Jiang C. Tumor Microenvironment-Triggered aggregated magnetic nanoparticles for reinforced Image-Guided Immunogenic chemotherapy. Adv Sci (Weinh). 2019;6(6):1802134.","journal-title":"Adv Sci (Weinh)"},{"key":"3164_CR17","doi-asserted-by":"publisher","first-page":"108922","DOI":"10.1016\/j.biopha.2019.108922","volume":"115","author":"X Xu","year":"2019","unstructured":"Xu X, Rajamanicham V, Xu S, Liu Z, Yan T, Liang G, Guo G, Zhou H, Wang Y. Schisandrin A inhibits triple negative breast cancer cells by regulating wnt\/er stress signaling pathway. Biomed Pharmacother. 2019;115:108922.","journal-title":"Biomed Pharmacother"},{"key":"3164_CR18","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/iub.2329","volume":"72","author":"H Yan","year":"2020","unstructured":"Yan H, Guo M. Schizandrin A inhibits cellular phenotypes of breast cancer cells by repressing miR-155. IUBMB Life. 2020;72:1640\u20138.","journal-title":"IUBMB Life"},{"issue":"5","key":"3164_CR19","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3892\/mmr.2021.12427","volume":"24","author":"H Pu","year":"2021","unstructured":"Pu H, Qian Q, Wang F, Gong M, Ge X. Schizandrin A induces the apoptosis and suppresses the proliferation, invasion and migration of gastric cancer cells by activating Endoplasmic reticulum stress. Mol Med Rep. 2021;24(5):787.","journal-title":"Mol Med Rep"},{"key":"3164_CR20","doi-asserted-by":"publisher","first-page":"114100","DOI":"10.1016\/j.colsurfb.2024.114100","volume":"242","author":"C Wang","year":"2024","unstructured":"Wang C, Wang B, Zhang Q, Zhang S. Tumor microenvironment-responsive cell-penetrating peptides: design principle and precision delivery. Colloids Surf B Biointerfaces. 2024;242:114100.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"19","key":"3164_CR21","doi-asserted-by":"publisher","first-page":"7380","DOI":"10.1021\/jacs.1c00451","volume":"143","author":"J Liu","year":"2021","unstructured":"Liu J, Chen H, Liu Y, Shen Y, Meng F, Kaniskan H\u00dc, Jin J, Wei W. Cancer selective target degradation by Folate-Caged protacs. J Am Chem Soc. 2021;143(19):7380\u20137.","journal-title":"J Am Chem Soc"},{"issue":"10","key":"3164_CR22","doi-asserted-by":"publisher","first-page":"786","DOI":"10.2174\/0113816128279071231204071210","volume":"30","author":"Y Li","year":"2024","unstructured":"Li Y, Jia G, Li T, Zhou X, Zhao H, Cao J, Guan Z, Zhao R. Preparation optimization and immunological activity studies of Portulaca oleracea L. Polysaccharides liposomes. Curr Pharm Des. 2024;30(10):786\u201397.","journal-title":"Curr Pharm Des"},{"key":"3164_CR23","doi-asserted-by":"publisher","first-page":"117192","DOI":"10.1016\/j.biopha.2024.117192","volume":"178","author":"H Yu","year":"2024","unstructured":"Yu H, Liu S, Yuan Z, Huang H, Yan P, Zhu W. Targeted co-delivery of Rapamycin and oxaliplatin by liposomes suppresses tumor growth and metastasis of colorectal cancer. Biomed Pharmacother. 2024;178:117192.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"3164_CR24","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.3390\/molecules28041577","volume":"28","author":"T Zhou","year":"2023","unstructured":"Zhou T, Liu Y, Lei K, Liu J, Hu M, Guo L, Guo Y, Ye Q. A Trojan horse strategy: the Preparation of bile Acid-Modifying Irinotecan hydrochloride nanoliposomes for Liver-Targeted anticancer drug delivery system study. Molecules. 2023;28(4):1577.","journal-title":"Molecules"},{"key":"3164_CR25","doi-asserted-by":"publisher","first-page":"124838","DOI":"10.1016\/j.ijpharm.2024.124838","volume":"666","author":"H Khalili-Hezarjaribi","year":"2024","unstructured":"Khalili-Hezarjaribi H, Bahrami AR, Sh Saljooghi A, Matin MM. Modified mesoporous silica nanocarriers containing superparamagnetic iron oxide nanoparticle, 5-fluorouracil or oxaliplatin, and Metformin as a radiosensitizer, significantly impact colorectal cancer radiation therapy. Int J Pharm. 2024;666:124838.","journal-title":"Int J Pharm"},{"issue":"1","key":"3164_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/pharmaceutics14010129","volume":"14","author":"H Shah","year":"2022","unstructured":"Shah H, Madni A, Khan MM, Ahmad FU, Jan N, Khan S, Rahim MA, Khan S, Ali MM, Kazi M. pH-Responsive liposomes of dioleoyl phosphatidylethanolamine and cholesteryl hemisuccinate for the enhanced anticancer efficacy of cisplatin. Pharmaceutics. 2022;14(1):129.","journal-title":"Pharmaceutics"},{"issue":"2","key":"3164_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.bbamem.2014.10.032","volume":"1848","author":"W Kulig","year":"2015","unstructured":"Kulig W, Jurkiewicz P, Ol\u017cy\u0144ska A, Tynkkynen J, Javanainen M, Manna M, Rog T, Hof M, Vattulainen I, Jungwirth P. Experimental determination and computational interpretation of biophysical properties of lipid bilayers enriched by cholesteryl hemisuccinate. Biochim Biophys Acta. 2015;1848(2):422\u201332.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"3164_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0005-2736(99)00186-8","volume":"1463","author":"IM Hafez","year":"2000","unstructured":"Hafez IM, Cullis PR. Cholesteryl hemisuccinate exhibits pH sensitive polymorphic phase behavior. Biochim Biophys Acta. 2000;1463(1):107\u201314.","journal-title":"Biochim Biophys Acta"},{"key":"3164_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2147\/DDDT.S150201","volume":"12","author":"YP Fang","year":"2018","unstructured":"Fang YP, Hu PY, Huang YB. Diminishing the side effect of mitomycin C by using pH-sensitive liposomes: in vitro characterization and in vivo pharmacokinetics. Drug Des Devel Ther. 2018;12:159\u201369.","journal-title":"Drug Des Devel Ther"},{"issue":"14","key":"3164_CR30","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1002\/smll.200801647","volume":"5","author":"C Fang","year":"2009","unstructured":"Fang C, Bhattarai N, Sun C, Zhang M. Functionalized nanoparticles with long-term stability in biological media. Small. 2009;5(14):1637\u201341.","journal-title":"Small"},{"issue":"4","key":"3164_CR31","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1166\/jbn.2009.1050","volume":"5","author":"S Mourtas","year":"2009","unstructured":"Mourtas S, Michanetzis GP, Missirlis YF, Antimisiaris SG. Haemolytic activity of liposomes: effect of vesicle size, lipid concentration and polyethylene glycol-lipid or arsonolipid incorporation. J Biomed Nanotechnol. 2009;5(4):409\u201315.","journal-title":"J Biomed Nanotechnol"},{"issue":"4","key":"3164_CR32","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1021\/acs.analchem.3c04242","volume":"96","author":"BS Wong","year":"2024","unstructured":"Wong BS, Dunnington EL, Wu R, Kim JI, Hu K, Ro TH, Fu D. Facilitated transport of EGFR inhibitors plays an important role in their cellular uptake. Anal Chem. 2024;96(4):1547\u201355.","journal-title":"Anal Chem"},{"issue":"9","key":"3164_CR33","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1021\/acs.accounts.8b00292","volume":"51","author":"J Mosquera","year":"2018","unstructured":"Mosquera J, Garc\u00eda I, Liz-Marz\u00e1n LM. Cellular uptake of nanoparticles versus small molecules: A matter of size. Acc Chem Res. 2018;51(9):2305\u201313.","journal-title":"Acc Chem Res"},{"issue":"10","key":"3164_CR34","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00249-012-0830-8","volume":"41","author":"G Caracciolo","year":"2012","unstructured":"Caracciolo G, Amenitsch H. Cationic liposome\/dna complexes: from structure to interactions with cellular membranes. Eur Biophys J. 2012;41(10):815\u201329.","journal-title":"Eur Biophys J"},{"issue":"6","key":"3164_CR35","doi-asserted-by":"publisher","first-page":"e3202","DOI":"10.1002\/btpr.3202","volume":"37","author":"S Kousani","year":"2021","unstructured":"Kousani S, Karimi M, Teymouri M, Navashenaq JG, Darban SA, Jaafari MR. Antennapedia-derived positively-charged peptide faces multiple problems upon their usage as targeting ligand for liposomal doxorubicin. Biotechnol Prog. 2021;37(6):e3202.","journal-title":"Biotechnol Prog"},{"issue":"1","key":"3164_CR36","first-page":"32","volume":"11","author":"S Zhao","year":"2019","unstructured":"Zhao S, Sun S, Jiang K, Wang Y, Liu Y, Wu S, Li Z, Shu Q, Lin H. In situ synthesis of fluorescent mesoporous Silica-Carbon Dot nanohybrids featuring folate Receptor-Overexpressing Cancer cell targeting and drug delivery. Nanomicro Lett. 2019;11(1):32.","journal-title":"Nanomicro Lett"},{"issue":"1","key":"3164_CR37","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1038\/s41467-023-38753-6","volume":"14","author":"M Zhan","year":"2023","unstructured":"Zhan M, Ding Y, Huang S, Liu Y, Xiao J, Yu H, Lu L, Wang X. Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase. Nat Commun. 2023;14(1):3123.","journal-title":"Nat Commun"},{"issue":"3","key":"3164_CR38","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.18632\/aging.202386","volume":"13","author":"D Li","year":"2021","unstructured":"Li D, Kou Y, Gao Y, Liu S, Yang P, Hasegawa T, Su R, Guo J, Li M. Oxaliplatin induces the PARP1-mediated parthanatos in oral squamous cell carcinoma by increasing production of ROS. Aging. 2021;13(3):4242\u201357.","journal-title":"Aging"},{"issue":"1","key":"3164_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/cdd.2013.75","volume":"21","author":"I Martins","year":"2014","unstructured":"Martins I, Wang Y, Michaud M, Ma Y, Sukkurwala AQ, Shen S, Kepp O, M\u00e9tivier D, Galluzzi L, Perfettini JL, Zitvogel L, Kroemer G. Molecular mechanisms of ATP secretion during Immunogenic cell death. Cell Death Differ. 2014;21(1):79\u201391.","journal-title":"Cell Death Differ"},{"issue":"9","key":"3164_CR40","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/nm1622","volume":"13","author":"L Apetoh","year":"2007","unstructured":"Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, Levi F, Lidereau R, Nogues C, Mira JP, Chompret A, Joulin V, Clavel-Chapelon F, Bourhis J, Andr\u00e9 F, Delaloge S, Tursz T, Kroemer G, Zitvogel L. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007;13(9):1050\u20139.","journal-title":"Nat Med"},{"issue":"6","key":"3164_CR41","doi-asserted-by":"publisher","first-page":"C1318","DOI":"10.1152\/ajpcell.00616.2005","volume":"291","author":"CW Bell","year":"2006","unstructured":"Bell CW, Jiang W, Reich CF 3rd, Pisetsky DS. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol. 2006;291(6):C1318\u201325.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"3164_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.34172\/bi.2022.23698","volume":"13","author":"S Jafari","year":"2023","unstructured":"Jafari S, Heydarian S, Lai R, Mehdizadeh Aghdam E, Molavi O. Silibinin induces Immunogenic cell death in cancer cells and enhances the induced Immunogenicity by chemotherapy. Bioimpacts. 2023;13(1):51\u201361.","journal-title":"Bioimpacts"},{"key":"3164_CR43","doi-asserted-by":"publisher","first-page":"122869","DOI":"10.1016\/j.biomaterials.2024.122869","volume":"314","author":"D Lin","year":"2025","unstructured":"Lin D, Lv W, Qian M, Jiang G, Lin X, Gantulga D, Wang Y. Engineering cell membrane-camouflaged COF-based nanosatellite for enhanced tumor-targeted photothermal chemoimmunotherapy. Biomaterials. 2025;314:122869.","journal-title":"Biomaterials"},{"issue":"1","key":"3164_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12307-011-0077-4","volume":"6","author":"LV Ramanathapuram","year":"2013","unstructured":"Ramanathapuram LV, Hopkin D, Kurago ZB. Dendritic cells (DC) facilitate detachment of squamous carcinoma cells (SCC), while SCC promote an immature CD16(+) DC phenotype and control DC migration. Cancer Microenviron. 2013;6(1):41\u201355.","journal-title":"Cancer Microenviron"},{"issue":"1","key":"3164_CR45","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm1523","volume":"13","author":"M Obeid","year":"2007","unstructured":"Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, M\u00e9tivier D, Larochette N, van Endert P, Ciccosanti F, Piacentini M, Zitvogel L, Kroemer G. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med. 2007;13(1):54\u201361.","journal-title":"Nat Med"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03164-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03164-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03164-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:33:18Z","timestamp":1757442798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03164-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3164"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03164-0","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"29 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study strictly followed the 3R principles and was approved by the Animal Committee of Heilongjiang Evidence-based Biotechnology Co., Ltd (Ethics No. 202312291). All methods are reported in accordance with ARRIVE guidelines for the reporting of animal experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1634"}}